Medicine
Prednisone 10 mg tablet
Prednisone 10 mg tablet is a generic prescription medicine for oral use, made by 33 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Blisters: Protect from light and moisture.
Key facts
- Active ingredient (INN)
- Prednisone
- Brand
- Sold under the generic name
- Strength
- 10 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 10 blister pack and 329 more
- Manufacturers
- Strides PharmaIndiaAurobindo PharmaIndiaActavis PharmaHikma PharmaceuticalsPar HealthA-S Medication SolutionsANI PharmaceuticalsAmneal Pharmaceuticals NYGranulation TechnologyMylan Pharmaceuticals33 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Blisters: Protect from light and moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A07EA03 Prednisone
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 December 1985
- Identifiers
- RxCUI 198145, 763185, 198146 +7DailyMed set ID 41ade439-59f2-dfd1-e063-6294a90aca0f, 19fdbf9f-3a64-b9fa-e063-6394a90af086, bf6ebe58-e7bb-49d3-842e-3372f8ba6172 +37NDC 72189-646, 72789-401, 87063-044 +37Application ANDA085162, ANDA211575, ANDA215672 +10
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 33 labelers. The register lists 332 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 59651-487-01 | Aurobindo PharmaIndia | 28 March 2022 |
| 500 tablet in 1 bottle | 59651-487-05 | Aurobindo PharmaIndia | 28 March 2022 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 59651-487-78 | Aurobindo PharmaIndia | 28 March 2022 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 64380-784-01 | Strides PharmaIndia | 1 September 2021 |
| 100 tablet in 1 bottle, plastic | 64380-784-06 | Strides PharmaIndia | 1 September 2021 |
| 500 tablet in 1 bottle, plastic | 64380-784-07 | Strides PharmaIndia | 1 September 2021 |
| 1000 tablet in 1 bottle, plastic | 64380-784-08 | Strides PharmaIndia | 1 September 2021 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 0054-0017-20 | Hikma Pharmaceuticals | 13 February 2003 |
| 100 tablet in 1 bottle, plastic | 0054-0017-25 | Hikma Pharmaceuticals | 13 February 2003 |
| 500 tablet in 1 bottle, plastic | 0054-0017-29 | Hikma Pharmaceuticals | 13 February 2003 |
| 100 tablet in 1 bottle | 0054-9817-25 | Hikma Pharmaceuticals | 23 March 2020 |
| 500 tablet in 1 bottle | 0054-9817-29 | Hikma Pharmaceuticals | 23 March 2020 |
| 100 tablet in 1 bottle | 0591-5442-01 | Actavis Pharma | 1 January 1990 |
| 500 tablet in 1 bottle | 0591-5442-05 | Actavis Pharma | 1 January 1990 |
| 1000 tablet in 1 bottle | 0591-5442-10 | Actavis Pharma | 18 May 1993 |
| 1 blister pack in 1 carton / 21 tablet in 1 blister pack | 0591-5442-21 | Actavis Pharma | 25 May 2016 |
| 1 blister pack in 1 carton / 48 tablet in 1 blister pack | 0591-5442-43 | Actavis Pharma | 25 May 2016 |
| 100 tablet in 1 bottle, plastic | 60219-1707-1 | Amneal Pharmaceuticals NY | 24 June 2020 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 60219-1707-3 | Amneal Pharmaceuticals NY | 24 June 2020 |
| 500 tablet in 1 bottle, plastic | 60219-1707-5 | Amneal Pharmaceuticals NY | 24 June 2020 |
| 100 tablet in 1 bottle | 70954-059-10 | ANI Pharmaceuticals | 15 November 2019 |
| 1000 tablet in 1 bottle | 70954-059-20 | ANI Pharmaceuticals | 15 November 2019 |
| 1 blister pack in 1 box / 21 tablet in 1 blister pack | 70954-059-30 | ANI Pharmaceuticals | 28 May 2020 |
| 1 blister pack in 1 box / 48 tablet in 1 blister pack | 70954-059-40 | ANI Pharmaceuticals | 28 May 2020 |
| 100 tablet in 1 bottle | 63561-0121-1 | Granulation Technology | 22 May 2025 |
| 1000 tablet in 1 bottle | 63561-0121-2 | Granulation Technology | 22 May 2025 |
| 500 tablet in 1 bottle | 63561-0121-5 | Granulation Technology | 22 May 2025 |
| 100 tablet in 1 bottle, plastic | 0378-0641-01 | Mylan Pharmaceuticals | 3 April 2019 |
| 1000 tablet in 1 bottle, plastic | 0378-0641-10 | Mylan Pharmaceuticals | 3 April 2019 |
| 21 tablet in 1 box, unit-dose | 0603-5338-15 | Par Health | 12 July 2002 |
| 100 tablet in 1 bottle, plastic | 0603-5338-21 | Par Health | 12 July 2002 |
| 500 tablet in 1 bottle, plastic | 0603-5338-28 | Par Health | 12 July 2002 |
| 48 tablet in 1 box, unit-dose | 0603-5338-31 | Par Health | 12 July 2002 |
| 1000 tablet in 1 bottle, plastic | 0603-5338-32 | Par Health | 12 July 2002 |
| 1 bottle in 1 box / 10 tablet in 1 bottle | 54348-506-10 | PharmPak | 12 July 2019 |
| 1 bottle in 1 box / 20 tablet in 1 bottle | 54348-506-20 | PharmPak | 12 July 2019 |
| 21 tablet in 1 box, unit-dose | 50090-1001-0 | A-S Medication Solutions | 28 November 2014 |
| 48 tablet in 1 box, unit-dose | 50090-1002-0 | A-S Medication Solutions | 28 November 2014 |
| 10 tablet in 1 bottle | 50090-3137-0 | A-S Medication Solutions | 2 October 2020 |
| 15 tablet in 1 bottle | 50090-3137-1 | A-S Medication Solutions | 6 September 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 February 1955 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Prednisone
Clinical summary
Prednisone is a corticosteroid indicated in the treatment of diseases or conditions, among other approved uses. It is available as tablets, delayed-release tablets and oral solution. MedsAcross supplies Prednisone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PrednisoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Prednisone delayed release prescribing information (Dr. Reddy's Laboratories) · U.S. National Library of Medicine, DailyMed
Need Prednisone 10 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.